The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
and this hormone was an in creedon so basically if you uh put it on beta cells um you get this increased response of insulin in response to glucose and so there was the idea okay this could be a great diabetes drug right
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
that's plausible at this point um and yeah i mean this class of drugs was identified based on its ability to increase glucose stimulated insulin secretion that is what glp1 does it's an incretin hormone and so that was the original purpose and why it was used in type 2 diabetes management because it gives people more insulin around meals when they really need it because you know if you just inject insulin that's a really kind of crude way to manage your blood glucose it's not time specific so glp-1 gave it that much needed time specificity